Clinical Trial Update: Comparison of Eplerenone Versus Spironolactone in Heart Failure Patients With Glucose Intolerance or Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing eplerenone to spironolactone in heart failure patients with glucose intolerance or Type 2 diabetes completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Type 2 Diabetes Mellitus

Drugs mentioned

• Spironolactone (spironolactone)
• eplerenone (eplerenone)

Snippet

Sponsor: Montreal Heart Institute | Conditions: Heart Failure, Type 2 Diabetes | Phase 3 | Status: COMPLETED